Dermatologic Therapy,
Journal Year:
2022,
Volume and Issue:
35(8)
Published: May 18, 2022
The
cutaneous
side
effects
of
COVID-19
vaccines
are
being
studied
and
their
immunogenicity
is
most
likely
linked
to
the
pathophysiology
psoriasis.
Although
uncommon,
several
cases
exacerbation
new
onset
psoriasis
have
been
reported
globally
after
vaccination.
To
contribute
literature
on
this
intriguing
topic,
we
present
three
de
novo
in
adult
patients
following
Our
observations
a
review
show
that
occurrence
independent
type
brand
vaccines.
Cureus,
Journal Year:
2022,
Volume and Issue:
unknown
Published: Feb. 27, 2022
Lichen
planus
is
an
autoimmune
inflammatory
disease
that
can
be
associated
with
infections,
drugs,
and
vaccines.
Recently,
it
has
been
reported
to
occur
following
mRNA-based
COVID-19
vaccines,
particularly
the
Pfizer/BioNTech
vaccine.
We
present
first
case
of
lichen
developed
after
five
days
administration
dose
Oxford-AstraZeneca
vaccine
in
a
46-year-old
healthy
male.
The
skin
eruption
was
purple,
ill-defined,
non-scaly,
itchy,
distributed
over
his
face,
abdomen,
back,
legs.
clinical
appearance
histopathology
confirmed
diagnosis
planus.
lesions
were
not
responding
well
topical
steroid
oral
antihistamine
treatment.
Thus,
patient
commenced
on
systemic
hydroxychloroquine.
Journal of Clinical Medicine,
Journal Year:
2022,
Volume and Issue:
11(3), P. 797 - 797
Published: Feb. 1, 2022
COVID
Vaccine
Arm
(CVA)
is
an
adverse
drug
reaction
from
mRNA
vaccine
for
SARS-CoV-2.
CVA
characterized
by
erythema
and
edema
on
the
vaccination
site
(usually
deltoid
area)
that
appears
5
to
10
days
after
sometimes
associated
with
itching
or
pain.
The
exact
etiology
of
still
unclear,
but
delayed
hypersensitivity
against
excipient
seems
play
essential
role
in
pathogenesis
disease.
This
work
performs
a
systematic
literature
review
using
three
different
databases
containing
articles
published
until
November
2021.
includes
eight
papers
reporting
single
cases
case
series
CVA.
Moreover,
it
also
addresses,
other
cutaneous
reactions
following
19
vaccinations
as
well
possible
differential
diagnosis.
migrans-like
ring-shaped
rash
injection
area,
which
some
disappears
about
days.
may
appear
more
rapidly
subsequent
doses.
Dermatologic Therapy,
Journal Year:
2022,
Volume and Issue:
35(11)
Published: Sept. 16, 2022
Urticaria
is
a
disease
characterized
by
wheals
and/or
angioedema.
Chronic
spontaneous
urticaria
(CSU)
occurs
for
longer
than
6
weeks
and
appears
independently
of
any
identifiable
exogenous
stimulus.
During
the
vaccination
campaign
Coronavirus
2019
(COVID-19)
pandemic,
several
cutaneous
adverse
events
have
been
described,
among
which
lasting
less
(acute
urticaria,
AU).
AU
due
to
vaccines
can
be
IgE
or
non-IgE
mediated;
former
typically
develop
within
4
h
drug
exposure,
latter
later
mechanism
unclear.
In
this
retrospective
study
we
analyzed
frequency
clinical
characteristics
occurring
after
COVID-19
vaccine
(post-vaccination
relapse)
in
adult
CSU
patients
treated
with
antihistamine
omalizumab,
remission.
Journal of Cosmetic Dermatology,
Journal Year:
2022,
Volume and Issue:
21(3), P. 883 - 885
Published: Jan. 8, 2022
None
of
the
authors
have
any
conflict
interest
to
disclose.
Data
sharing
is
not
applicable
this
article
as
no
new
data
were
created
or
analyzed
in
study.
Dermatologic Therapy,
Journal Year:
2022,
Volume and Issue:
35(8)
Published: May 18, 2022
The
cutaneous
side
effects
of
COVID-19
vaccines
are
being
studied
and
their
immunogenicity
is
most
likely
linked
to
the
pathophysiology
psoriasis.
Although
uncommon,
several
cases
exacerbation
new
onset
psoriasis
have
been
reported
globally
after
vaccination.
To
contribute
literature
on
this
intriguing
topic,
we
present
three
de
novo
in
adult
patients
following
Our
observations
a
review
show
that
occurrence
independent
type
brand
vaccines.
